Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep:6:113-117.
doi: 10.1016/j.jgar.2016.04.008. Epub 2016 May 30.

Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar

Affiliations

Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar

Htin Lin Aung et al. J Glob Antimicrob Resist. 2016 Sep.

Abstract

Drug-resistant tuberculosis (TB) is a major health threat in Myanmar. An initial study was conducted to explore the potential utility of whole-genome sequencing (WGS) for the diagnosis and management of drug-resistant TB in Myanmar. Fourteen multidrug-resistant Mycobacterium tuberculosis isolates were sequenced. Known resistance genes for a total of nine antibiotics commonly used in the treatment of drug-susceptible and multidrug-resistant TB (MDR-TB) in Myanmar were interrogated through WGS. All 14 isolates were MDR-TB, consistent with the results of phenotypic drug susceptibility testing (DST), and the Beijing lineage predominated. Based on the results of WGS, 9 of the 14 isolates were potentially resistant to at least one of the drugs used in the standard MDR-TB regimen but for which phenotypic DST is not conducted in Myanmar. This study highlights a need for the introduction of second-line DST as part of routine TB diagnosis in Myanmar as well as new classes of TB drugs to construct effective regimens.

Keywords: Drug-resistant TB; Myanmar; Whole-genome sequencing.

PubMed Disclaimer

Similar articles

Cited by

References

    1. World Health Organization . WHO; Geneva, Switzerland: 2014. Global tuberculosis report 2014.
    1. Koser C.U., Bryant J.M., Becq J., Torok M.E., Ellington M.J., Marti-Renom M.A. Whole-genome sequencing for rapid susceptibility testing of M tuberculosis. N Engl J Med. 2013;369:290–292. - PMC - PubMed
    1. Koser C.U., Ellington M.J., Cartwright E.J., Gillespie S.H., Brown N.M., Farrington M. Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog. 2012;8:e1002824. - PMC - PubMed
    1. Walker T.M., Kohl T.A., Omar S.V., Hedge J., Del Ojo Elias C., Bradley P. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis. 2015;15:1193–1202. - PMC - PubMed
    1. National TB Programme Myanmar . National TB Programme Myanmar; 2013. Guidelines for the management of multidrug-resistant tuberculosis (MDR-TB) in Myanmar.

Publication types

Substances